Editorial overview: Anti-infectives: Current challenges and unmet needs in antimicrobial therapy

Current Opinion in Pharmacology

Volumn 24, Issue , 2015, Pages iv-vi

  Pea, Federico ^a,b  

^a SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; BETA LACTAM; PYRROLE; TRIAZOLE;

AGING; ANTIMICROBIAL THERAPY; BACTERIAL INFECTION; BODY SIZE; BODY WEIGHT; CRITICALLY ILL PATIENT; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; FRAIL ELDERLY; GRAM NEGATIVE BACTERIUM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INTENSIVE CARE; KIDNEY FAILURE; MULTIDRUG RESISTANCE; MYCOSIS; OBESITY; POLYPHARMACY; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RISK FACTOR; SEPSIS; TREATMENT DURATION; BACTERIAL INFECTIONS; CRITICAL ILLNESS; DRUG INTERACTION; ORGAN TRANSPLANTATION;

ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; CRITICAL ILLNESS; DRUG INTERACTIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; ORGAN TRANSPLANTATION;

EID: 84949106148     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2015.08.001     Document Type: Editorial

References (10)

1. F. Pea Plasma pharmacokinetics of antimicrobial agents in critically ill patients Curr Clin Pharmacol 8 2013 5 12
2. K.A. Kaspersen, O.B. Pedersen, M.S. Petersen, H. Hjalgrim, K. Rostgaard, B.K. Moller, C. Juul-Sorensen, S. Kotze, K.M. Dinh, L.T. Erikstrup, and et al. Obesity and risk of infection: results from the danish blood donor study Epidemiology 26 2015 580 589
3. S. Harper Economic and social implications of aging societies Science 346 2014 587 591
4. C. Tannenbaum How to treat the frail elderly: the challenge of multimorbidity and polypharmacy Can Urol Assoc J 7 2013 S183 S185
5. R.P. Dellinger, M.M. Levy, A. Rhodes, D. Annane, H. Gerlach, S.M. Opal, J.E. Sevransky, C.L. Sprung, I.S. Douglas, R. Jaeschke, and et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012 Intensive Care Med 39 2013 165 228
6. M. Poukkanen, J. Koskenkari, S.T. Vaara, V. Pettila, S. Karlsson, A.M. Korhonen, J.J. Laurila, K.M. Kaukonen, V. Lund, T.I. Ala-Kokko, and et al. Variation in the use of renal replacement therapy in patients with septic shock: a substudy of the prospective multicenter observational FINNAKI study Crit Care 18 2014 R26
7. F. Pea, P. Viale, F. Pavan, and M. Furlanut Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy Clin Pharmacokinet 46 2007 997 1038
8. G.L. Kearns, S.M. Abdel-Rahman, S.W. Alander, D.L. Blowey, J.S. Leeder, and R.E. Kauffman Developmental pharmacology - drug disposition, action, and therapy in infants and children N Engl J Med 349 2003 1157 1167
9. J. Gavalda, Y. Meije, J. Fortun, E. Roilides, F. Saliba, O. Lortholary, P. Munoz, P. Grossi, M. Cuenca-Estrella, and ESGfIiC. Hosts Invasive fungal infections in solid organ transplant recipients Clin Microbiol Infect 20 Suppl. 7 2014 27 48
10. I. Martin-Loeches, E. Diaz, and J. Valles Risks for multidrug-resistant pathogens in the ICU Curr Opin Crit Care 20 2014 516 524